Section
Policy
IRA, state PBM reform, Medicare, and regulatory action
PolicyFiercePharma ↗
Eleventh-hour settlements with two of the three generic drugmakers involved could bode well for both Pfizer an…
PolicyEndpoints News ↗
When the Supreme Court hears arguments this week over a prescription-strength pill derived from fish oil, the …
PolicySTAT News ↗
The Supreme Court Wednesday will hear oral arguments about a simmering controversy over so-called skinny label…
PolicySTAT News ↗
The Supreme Court seemed divided Monday over whether to block thousands of lawsuits alleging the maker of the …
PolicyFierceBiotech ↗
The FDA is awarding national priority vouchers to Compass Pathways, Usona Institute and Transcend Therapeutics…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.